Home › Markets › Industrials › EVGN

Evogene Ltd (EVGN)

EVGN trades on Nasdaq in Industrials, Agricultural Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$0.3902
+0.96% on the day
Market cap
$6.2M
Nano cap
Revenue · 2025
$3.9M
No prior year to compare
Net income · 2025
-$8.5M
-220.2% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/0001178913-26-001767-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), period ending 2025-12-31.

Profile

FieldValue
TickerEVGN on Nasdaq
SectorIndustrials
IndustryAgricultural Chemicals
CountryIsrael
IPO yearNot reported by the screener
SEC CIK0001574565
SEC industry codeAgricultural Chemicals
Incorporated inL3

Financials · 2025

LineValue
Revenue$3.9M
Net income-$8.5M
Operating incomeNot in SEC XBRL data
Net margin-220.2%
Operating marginOperating income not reported
Revenue growthNo prior-year revenue to compare
CashNot in SEC XBRL data
Total assetsNot in SEC XBRL data
P/E (computed)Net income was not positive
P/S (computed)1.6×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentPOS AM2026-09-28
Latest annual report20-F2026-03-26
Latest quarterly / interim6-K2026-10-06

Source: SEC EDGAR submissions feed, 460 recent filings. All filings on EDGAR.

Peers in Agricultural Chemicals

TickerCompanyPriceDayMarket cap
FRTTFort Technology Inc. Common Shares$0.6960-7.08%$10.5M
SNESSenesTech Inc.$0.6293-2.87%$3.4M
BIOXBioceres Crop Solutions Corp.$0.3250-1.81%$20.7M
NXTSNexentis Technologies Inc.$0.7038-6.88%$1.0M
AVDAmerican Vanguard Corporation Common Stock ($0.10 Par Value)$1.33-5.67%$39.2M
CBUSCibus Inc.$1.41-4.73%$107.8M
UANCVR Partners LP Common Units representing Limited Partner Interests$126.21+0.57%$1.3B
SMGScotts Miracle-Gro Company (The)$50.10+0.32%$2.9B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier